Participants with depression had significantly lower GFAP compared with participants without depression overall (median = 149.9 pg/mL versus 306.9 pg/mL, P < 0.001) and CT-negative high risk and CT-negative low risk subgroups. Here, GFAP is linked to depressive symptom measurement.